Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validation of a Set of Potential Biomarkers Predictive of Bone Complications in Type 1 Gaucher Disease Patients

NCT05702814 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT05702814
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05702814 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validation of a Set of Potential Biomarkers Predictive of Bone Complications in Type 1 Gaucher Disease Patients
Lead sponsor
Takeda
Phase
Observational
Overall status
Completed
Start date
March 27, 2023
Completion date
May 24, 2024
Enrollment
125 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gaucher disease